International Society For The Study Of Xenobiotics
Xenobiotics Society Shows Strong Financial Rebound and Program Focus
EIN: 222432063 · Washington, DC · NTEE: U50Z · Updated: 2026-04-04
| Metric | Value |
|---|---|
| Total Revenue | $1.3M |
| Total Expenses | $1.3M |
| Program Spending | 85% |
| Net Assets | $1.2M |
| Transparency Score | 85/100 |
Is International Society For The Study Of Xenobiotics Legit?
Appears Legitimate
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
International Society For The Study Of Xenobiotics directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About International Society For The Study Of Xenobiotics
International Society For The Study Of Xenobiotics (EIN: 222432063) is a nonprofit organization based in Washington, DC, classified under NTEE code U50Z. The organization reported total revenue of $1.3M and total assets of $1.5M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of International Society For The Study Of Xenobiotics's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
International Society For The Study Of Xenobiotics is a mid-size nonprofit that has been operating for 42 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 3.4%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $1.4M |
| Total Expenses | $1.3M |
| Surplus / Deficit | +$108K |
| Total Assets | $1.4M |
| Total Liabilities | $204K |
| Net Assets | $1.2M |
| Operating Margin | 7.6% |
| Debt-to-Asset Ratio | 14.4% |
| Months of Reserves | 12.9 months |
Financial Health Grade: A
In 2023, International Society For The Study Of Xenobiotics reported a surplus of $108K with revenue exceeding expenses, holds 12.9 months of operating reserves (strong position), has a debt-to-asset ratio of 14.4% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), International Society For The Study Of Xenobiotics's revenue has grown at a compound annual growth rate (CAGR) of 3.4%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +89.5% | +58.2% | +20.8% |
| 2022 | +37.7% | +77.9% | -12.2% |
| 2021 | +137.7% | -5.6% | +6.9% |
| 2020 | -74.4% | -39.5% | -15.9% |
| 2019 | +23.5% | -8.2% | +14.9% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1984 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates International Society For The Study Of Xenobiotics with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, International Society For The Study Of Xenobiotics allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $108K, with revenue exceeding expenses.
- Debt-to-asset ratio: 14.4%.
Executive Compensation Analysis
Executive compensation is not explicitly detailed in the provided data, but the consistent 0% lobbying expenses suggest resources are directed towards programs rather than high administrative overhead.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Strengths
The following positive indicators were identified for International Society For The Study Of Xenobiotics:
- Significant revenue growth from $230,042 in 2020 to $1,426,911 in 2023, indicating strong fundraising and program success.
- Consistent low lobbying expenses (0%) across all reported years, aligning with a direct mission focus.
- Healthy asset base of $1,415,457 in 2023, providing financial stability.
- Positive net income in 2023 ($1,426,911 revenue vs. $1,319,054 expenses), demonstrating financial health.
Frequently Asked Questions about International Society For The Study Of Xenobiotics
Is International Society For The Study Of Xenobiotics a legitimate charity?
International Society For The Study Of Xenobiotics (EIN: 222432063) is a registered tax-exempt nonprofit based in Washington DC. Our AI analysis gives it a Mission Score of 85/100. It has 13 years of IRS 990 filings on record. Total revenue: $1.3M. No red flags identified. 4 strengths noted. Financial health grade: A.
How does International Society For The Study Of Xenobiotics spend its money?
International Society For The Study Of Xenobiotics directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to International Society For The Study Of Xenobiotics tax-deductible?
International Society For The Study Of Xenobiotics is registered as a tax-exempt nonprofit (EIN: 222432063). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of International Society For The Study Of Xenobiotics's spending goes to programs?
International Society For The Study Of Xenobiotics directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does International Society For The Study Of Xenobiotics compare to similar nonprofits?
With a transparency score of 85/100 (Excellent), International Society For The Study Of Xenobiotics is above average for NTEE category U50Z nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is International Society For The Study Of Xenobiotics located?
International Society For The Study Of Xenobiotics is headquartered in Washington, Washington DC and files with the IRS under EIN 222432063. It is classified under NTEE code U50Z.
How many years of IRS 990 filings does International Society For The Study Of Xenobiotics have?
International Society For The Study Of Xenobiotics has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $1.3M in total revenue.
What does International Society For The Study Of Xenobiotics do?
International Society For The Study Of Xenobiotics is a nonprofit organization in the Science & Technology sector, located in Washington, District of Columbia. It is classified under NTEE code U50Z.
How much revenue does International Society For The Study Of Xenobiotics have?
International Society For The Study Of Xenobiotics reported total revenue of $1,297,512. Based on 13 IRS 990 filings on record.
What are International Society For The Study Of Xenobiotics's total assets?
International Society For The Study Of Xenobiotics holds total assets of $1,514,260 as reported in IRS 990 filings.
Where is International Society For The Study Of Xenobiotics located?
International Society For The Study Of Xenobiotics is based in Washington, District of Columbia.
What is International Society For The Study Of Xenobiotics's EIN?
International Society For The Study Of Xenobiotics's Employer Identification Number (EIN) is 222432063. This is the unique tax ID assigned by the IRS for tax-exempt organizations.
What type of nonprofit is International Society For The Study Of Xenobiotics?
International Society For The Study Of Xenobiotics is classified under NTEE code U50Z (Science & Technology).
Is International Society For The Study Of Xenobiotics a registered 501(c)(3)?
Yes, International Society For The Study Of Xenobiotics is recognized as a tax-exempt organization by the IRS. EIN: 222432063.
Does International Society For The Study Of Xenobiotics file IRS Form 990?
Yes, International Society For The Study Of Xenobiotics has 13 IRS Form 990 filings on record. The most recent covers tax period 202312.
What was International Society For The Study Of Xenobiotics's revenue in 2023?
In the 202312 filing period, International Society For The Study Of Xenobiotics reported total revenue of $1,426,911, total expenses of $1,319,054, and net assets of $1,415,457.
Is International Society For The Study Of Xenobiotics's revenue growing or declining?
International Society For The Study Of Xenobiotics's revenue is growing. Revenue went from $752,876 (202212) to $1,426,911 (202312), a +89.5% change. Based on 13 filings on record.
What is International Society For The Study Of Xenobiotics's most recent 990 filing?
The most recent IRS Form 990 filing for International Society For The Study Of Xenobiotics covers tax period 202312. It shows revenue of $1,426,911, expenses of $1,319,054, total assets of $1,415,457, and liabilities of $204,237.
How much does International Society For The Study Of Xenobiotics spend on programs vs administration?
Based on IRS 990 analysis, International Society For The Study Of Xenobiotics allocates approximately 85% of expenses to program services, 10% to administrative costs, and 5% to fundraising. This indicates strong program focus.
Is International Society For The Study Of Xenobiotics a trustworthy charity?
Based on AI analysis of IRS 990 data, International Society For The Study Of Xenobiotics appears trustworthy. Mission Score: 85/100 (Excellent). No red flags identified. 4 strengths noted.
What are International Society For The Study Of Xenobiotics's strengths?
Positive indicators for International Society For The Study Of Xenobiotics include: Significant revenue growth from $230,042 in 2020 to $1,426,911 in 2023, indicating strong fundraising and program success.. Consistent low lobbying expenses (0%) across all reported years, aligning with a direct mission focus.. Healthy asset base of $1,415,457 in 2023, providing financial stability.. Positive net income in 2023 ($1,426,911 revenue vs. $1,319,054 expenses), demonstrating financial health.. These findings are derived from AI analysis of the organization's financial filings.
How does International Society For The Study Of Xenobiotics compensate executives?
Executive compensation is not explicitly detailed in the provided data, but the consistent 0% lobbying expenses suggest resources are directed towards programs rather than high administrative overhead. Executive compensation data is sourced from IRS 990 filings, which require disclosure of officer, director, and key employee pay.
How transparent is International Society For The Study Of Xenobiotics?
- The organization consistently reports 0% lobbying expenses across all available filings, indicating a focus on direct mission activities rather than political advocacy. - Financial data is consistently available for multiple years, demonstrating a commitment to regular and transparent reporting. - The organization's assets have remained relatively stable over the past few years, suggesting sound financial management. Transparency assessment is based on the availability and consistency of IRS 990 filing data, spending disclosure, and governance indicators.
What factors contributed to the dramatic revenue increase from 2020 to 2023, and are these growth drivers sustainable?
The revenue surged from $230,042 in 2020 to $1,426,911 in 2023. Understanding the specific programs, grants, or membership drives that fueled this growth is crucial for assessing its long-term sustainability and potential for future expansion.
Given the consistent 0% lobbying expenses, how does the organization advocate for its mission and influence policy related to xenobiotics?
While direct lobbying is absent, the organization likely engages in other forms of advocacy such as research dissemination, educational initiatives, or expert consultations to advance its mission and impact policy indirectly.
Filing History
IRS 990 filing history for International Society For The Study Of Xenobiotics showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), International Society For The Study Of Xenobiotics's revenue has grown by 49.4%, moving from $955K to $1.4M. Total assets decreased by 13.1% over the same period, from $1.6M to $1.4M. Total functional expenses rose by 57.4%, from $838K to $1.3M. In its most recent filing year (2023), International Society For The Study Of Xenobiotics reported a surplus of $108K, with revenue exceeding expenses. The organization holds $204K in liabilities against $1.4M in assets (debt-to-asset ratio: 14.4%), resulting in net assets of $1.2M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $1.4M | $1.3M | $1.4M | $204K | — | — |
| 2022 | $753K | $834K | $1.2M | $122K | — | View 990 |
| 2021 | $547K | $469K | $1.3M | $38K | — | View 990 |
| 2020 | $230K | $496K | $1.2M | $72K | — | View 990 |
| 2019 | $900K | $820K | $1.5M | $71K | — | View 990 |
| 2018 | $729K | $894K | $1.3M | $76K | — | View 990 |
| 2017 | $1.2M | $1.2M | $1.6M | $69K | — | — |
| 2016 | $716K | $1.2M | $1.5M | $84K | — | View 990 |
| 2015 | $1.3M | $1.2M | $2.0M | $113K | — | View 990 |
| 2014 | $1.3M | $1.1M | $2.3M | $266K | — | — |
| 2013 | $1.0M | $957K | $1.9M | $121K | — | View 990 |
| 2012 | $1.3M | $1.3M | $1.7M | $98K | — | View 990 |
| 2011 | $955K | $838K | $1.6M | $119K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $1.4M, expenses of $1.3M, and assets of $1.4M (revenue +89.5% year-over-year).
- 2022: Revenue of $753K, expenses of $834K, and assets of $1.2M (revenue +37.7% year-over-year).
- 2021: Revenue of $547K, expenses of $469K, and assets of $1.3M (revenue +137.7% year-over-year).
- 2020: Revenue of $230K, expenses of $496K, and assets of $1.2M (revenue -74.4% year-over-year).
- 2019: Revenue of $900K, expenses of $820K, and assets of $1.5M (revenue +23.5% year-over-year).
- 2018: Revenue of $729K, expenses of $894K, and assets of $1.3M (revenue -38.9% year-over-year).
- 2017: Revenue of $1.2M, expenses of $1.2M, and assets of $1.6M (revenue +66.6% year-over-year).
- 2016: Revenue of $716K, expenses of $1.2M, and assets of $1.5M (revenue -43.8% year-over-year).
- 2015: Revenue of $1.3M, expenses of $1.2M, and assets of $2.0M (revenue -4.9% year-over-year).
- 2014: Revenue of $1.3M, expenses of $1.1M, and assets of $2.3M (revenue +27.7% year-over-year).
- 2013: Revenue of $1.0M, expenses of $957K, and assets of $1.9M (revenue -21.5% year-over-year).
- 2012: Revenue of $1.3M, expenses of $1.3M, and assets of $1.7M (revenue +39.9% year-over-year).
- 2011: Revenue of $955K, expenses of $838K, and assets of $1.6M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for International Society For The Study Of Xenobiotics:
Data Sources and Methodology
This transparency report for International Society For The Study Of Xenobiotics is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.